Seizures in HIV-seropositive individuals: NIMHANS experience and review

Epilepsia

Volumn 49, Issue SUPPL.6, 2008, Pages 33-41

  Satishchandra, P ^a   Sinha, Sanjib ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Acquired immune deficiency syndrome (AIDS); Antiepileptic drugs; Epilepsy; Human immunodeficiency virus (HIV); Seizures

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; CARBAMAZEPINE; CLOBAZAM; COCAINE; CYTOCHROME P450; ETIRACETAM; GABAPENTIN; INDINAVIR; PHENOBARBITAL; PHENYTOIN; RITONAVIR; TIAGABINE; VALPROIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOLISM; BEHAVIOR DISORDER; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCAL MENINGITIS; DEMENTIA; ELECTROENCEPHALOGRAM; ELECTROLYTE DISTURBANCE; EPILEPTIC STATE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPENIA; LIVER DYSFUNCTION; LIVER METABOLISM; LYMPHOMA; METABOLIC DISORDER; METABOLIC ENCEPHALOPATHY; MONONEUROPATHY MULTIPLEX; MYELORADICULOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN BINDING; RASH; RECURRENT DISEASE; REVIEW; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINAL CORD DISEASE; STROKE; THROMBOCYTOPENIA; TOXOPLASMOSIS; TUBERCULOSIS; VIRUS REPLICATION;

ANTICONVULSANTS; BRAIN; CATCHMENT AREA (HEALTH); DRUG INTERACTIONS; ELECTROENCEPHALOGRAPHY; EPILEPSY; HIV INFECTIONS; HUMANS; INCIDENCE; INDIA; OPPORTUNISTIC INFECTIONS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 50249138288     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01754.x     Document Type: Review

References (55)

1. Aronow HA, Feraru ER, Lipton RB 1989) New-onset seizures in AIDS patients: etiology, prognosis, and treatment. Neurology 39 (Suppl. 1 428.
2. Bacellar H, Munoz A, Miller EN, Cohen BA, Besley D, Selnes OA, Becker JT, McArthur JC 1994) Temporal trends in the incidence of HIV-1 related neurologic disease: multicenter AIDS cohort study. Neurology 44 : 1892 1900.
3. Barry M, Gibbons S, Back D, Mulcahy F 1997) Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations. Clin Pharmacokinet 32 : 194 209.
4. Benedetti MS 2000) Enzyme induction and inhibition by new antiepileptic drugs: a review of human trials. Fundam Clin Pharmacol 14 : 301 319
5. Berbel-Garcia A, Latorre Ibarra A, Porta Etessam J, Martinez Salio A, Perez Martinez D, Siaz Diaz R, Toledo Heras M 2000) Protease inhibitor-induced carbamazepine toxicity. Clin Neuropharmacol 23 : 216 218.
6. Chadha DS, Handa A, Sharma SK, Varadarajulu P, Singh AP 2000) Seizures in patients with HIV infection. J Assoc Physicians India 48 : 573 576.
7. Cury RF, Wichert-Ana L, Sakamoto AC, Fernandes RM 2004) Focal non-convulsive status epilepticus associated to PLEDs and intense focal hyperaemia in an AIDS patient. Seizure 13 : 358 361.
8. Daikos GL, Cleary T, Rodriguez A, Fischl MA 2003) Multidrug-resistant tuberculous meningitis in patients with AIDS. Int J Tuberc Lung Dis 7 : 394 398.
9. Dal Pan GJ, McArthur JC, Harrison MJG 1997) Neurological symptoms in HIV infection. In Berger JR, Levy RM (Eds) AIDS and nervous system. 2nd edition. Lippincott-Raven, Philadelphia, USA, pp. 141 172.
10. Delanty N, Vaughan CJ, French JA 1998) Medical causes of seizures. Lancet 352 : 383 390.
11. Desai J 2008) Perspectives on interactions between antiepileptic drugs and antimicrobial agents. Epilepsia 49 (Suppl. 6 47 49.
12. Dore GJ, Law MG, Brew BJ 1996) Prospective analysis of seizures occurring in human immunodeficiency virus type-1 infection. J Neuro AIDS 1 : 59 69.
13. Enzensberger W, Fischer PA, Helm EB, Stille W 1985) Value of EEG in AIDS. Lancet 1 : 1047 1048.
14. Garg RK 1999) HIV medicine: HIV infection and seizures. Postgrad Med J 75 : 387 390.
15. Holtzman DM, Kaku DA, So YT 1989) New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases. Am J Med 87 : 173 177.
16. Hurwitz AA, Berman JW, Lyman WD 1994) The role of blood- brain barrier in HIV infection of the central nervous system. Adv Neuroimmunol 4 : 249 256.
17. Kato Y, Fujii T, Mizoguchi N, Takata N, Ueda K, Feldman MD, Kayser SR 2000) Potential interaction between ritonavir and carbamazepine. Pharmacotherapy 20 : 851 854.
18. Kellinghaus C, Engbring C, Kovac S, Möddel G, Boesebeck F, Fischera M, Anneken K, Klönne K, Reichelt D, Evers S, Husstedt IW 2008) Frequency of seizures and epilepsy in neurological HIV-infected patients. Seizure 17 : 27 33.
19. Kuntz-Simon G, Orbert G 1995) Sodium valproate, an anticonvulsant, stimulates human cytomegalovirus replication. J Gen Virol 76 : 151 158.
20. Lauer MS, Rhoney DM 1998) Tiagabine: a novel antiepileptic drug. Ann Pharmacother 32 : 1173 1180.
21. Lechner C, Auer D, Kumpfel T, Hesse J, Fuchs HH 1998) Prolonged non-convulsive status epilepticus as an early clinical manifestation of epilepsy in connection with HIV infection - case report with EEG and MRI follow up. Fortschr Neurol Psychiatr 66 : 326 330.
22. Lin RY, Smith JK 1988) Hyper -IgE and human immunodeficiency virus infection. Ann Allergy 61 : 269 272.
23. Lipton SA 1994) AIDS-related dementia and calcium homeostasis. Ann NY Acad Sci 747 : 205 224.
24. Lor E, Liu YQ 1994) Neurological sequelae associated with foscarnet therapy. Ann Pharmacother 28 : 1035 1037.
25. Mazza DS, Grieco MH, Reddy MM, Meriney D 1995) Serum IgE in patients with human immunodeficiency virus infection. Ann Allergy Asthma Immunol 74 : 411 414.
26. McDermott AY, Shevitz A, Knox T, Roubenoff R, Kehayias J, Gorbach S 2001) Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women. Am J Clin Nutr 74 : 679 686.
27. Millogo A, Lankoande D, Yameogo I, Yaméogo AA, Sawadogo A, Sawadogo AB 2004) New-onset seizures in patients with immunodeficiency virus infection in Bobo-Dioulasso Hospital. Bull Soc Pathol Exot 97 : 268 270.
28. Modi G, Modi M, Martinus I, Saffer D 2000) New-onset seizures associated with HIV infection. Neurology 55 : 1558 1561.
29. Moog C, Kuntz-Simon G, Caussin-Schwemling C, Obert G 1996) Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels. J Gen Virol 196 : 496 505.
30. Moulignier A, Mikol J, Pialoux G, Fenelon G, Gray F, Thiebaut JB 1995) AIDS-associated progressive multifocal leukoencephalopathy revealed by new-onset seizures. Am J Med 99 : 64 68.
31. Navia B, Jordan B, Price R 1986) The AIDS dementia complex: I clinical features. Ann Neurol 19 : 517 524.
32. Ozkaya G, Kurne A, Unal S Oǧuz KK, Karabudak R, Saygi S 2006) Aphasic status epilepticus with periodic lateralized epileptiform discharges in a bilingual patient as a presenting sign of "AIDS-toxoplasmosis complex." Epilepsy Behav 9 : 193 196.
33. Pack AM, Morrell AJ 2001) Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms, and therapeutic implications. CNS Drugs 15 : 633 642.
34. Pascual-Sedano B, Iranzo A, Marti-Fabregas J, Domingo P, Escartin A, Fuuster M, Barrio JL, Sambeat MA 1999) Prospective study of new-onset seizures in patients with HIV infection: etiologic and clinical aspects. Arch Neurol 56 : 609 612.
35. Pesola GR, Westfal RE 1998) New-onset generalized seizures with AIDS presenting at an emergency department. Acad Emerg Med 5 : 905 911.
36. Provenzale JM, Jinkins JR 1997) Brain and spine imaging findings in AIDS patients. Radiol Clin North Am 35 : 1127 1166.
37. Rachlis AR 1998) Neurologic manifestations of HIV infection. Postgrad Med 103 : 1 11.
38. Report of the Quality Standards Subcommittee of the American Academy of Neurology 1998) Evaluation and management of intracranial mass lesions in AIDS. Neurology 50 : 21 26.
39. Romanelli F, Jennings HR, Nath A, Ryan M, Berger J 2000) Therapeutic dilemma: the use of anticonvulsants in HIV positive individuals. Neurology 54 : 1404 1407.
40. Romanelli F, Ryan M 2002) Seizures in HIV seropositive individuals: epidemiology and treatment. CNS drugs 16 : 91 98.
41. Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi V, Desai A, Chandramuki A, Jayakumar PN, Shankar SK 2000) Profile of neurologic disorders associated with HIV/AIDS from Bangalore, South India (1989-96). Indian J Med Res 111 : 14 23.
42. Satishchandra P, Mathew P, Gadre G, Nagarathna S, Chandramukhi A, Mahadevan A, Shankar SK 2007) Cryptococcal meningitis: clinical, diagnostic and therapeutic overview. Neurol India 55 : 226 232.
43. Shobha N, Satishchandra P, Mahadevan A, Desai A, Ravi V, Shankar SK 2005) Clinical, radiological and pathological features of progressive multifocal leukoencephalopathy (PML) associated HIV clade C infection unpublished observations).
44. Shobha N, Satishchandra P, Desai A, Jayakumar PN, Ravi V, Shankar SK 2006) Seizure as the initial manifestation of cerebral toxoplasmosis in HIV clade C infected patients. Presented at an International CME, at Chennai, India, February 10-12, 2006.
45. Sinha S, Satishchandra P 2003) Nervous system involvement in asymptomatic HIV seropositive individuals - a cognitive and electrophysiological study. Neurol India 51 : 466 469.
46. Sinha S, Satishchandra P, Nalini A, Ravi V, Subbakrishna DK, Jayakumar PN, Chandramuki A, Shankar SK 2005) New-onset seizures among HIV infected drug naïve patients from south India. Neurology Asia 10 : 29 33.
47. Solomon BA, Haut SR, Carr EM, Shlita AR 1995) Neurotoxic reaction to lindane in an HIV seropositive patient. An old medication's new problem. J Fam Pract 40 : 291 296.
48. Staal FT, Roederer M, Israelski DM, Bubp J, Mole LA, McShane D, Deresinski SC, Ross W. Sussman H, Raju PA 1992) Intracellular glutathione levels in T-cell subsets decrease in HIV infected individuals. AIDS Res Hum Retroviruses 8 : 305 311.
49. Tseng AL, Foisy M 1999) Significant interactions with new antiretrovirals and psychotropic drugs. Ann Pharmacother 33 : 461 473.
50. Udgirkar VS, Tullu MS, Bavdekar SB, Shaharao VB, Kamat JR, Hira PR 2003) Neurological manifestations of HIV infection. Indian Pediatr 40 : 230 234.
51. UNAIDS and WHO. Report on the global HIV/AIDS epidemic update, UNAIDS. UNAIDS/07.27E / JC1322E (English original, December 2007).
52. USPHS/IDSA 1999) 1999 guidelines for the prevention and treatment of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 48 : 1 59.
53. Van Paesschen W, Bodian C, Maker H 1995) Metabolic abnormalities and new-onset seizures in human immunodeficiency virus - seropositive patients. Epilepsia 36 : 146 150.
54. Wong MC, Suite NDA, Labar DR 1990) Seizures in human immunodeficiency virus infection. Arch Neurol 47 : 640 642.
55. Zimmerman CL, Wen Y, Soria I, Pithavala YK 1997) Evaluation of gastrointestinal absorption and metabolism. Drug Metab Rev 29 : 957 975.